MedPath

Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients

Not Applicable
Terminated
Conditions
Sedation
Interventions
Registration Number
NCT01170247
Lead Sponsor
University of Iowa
Brief Summary

The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • pediatric patients age 2 to 17 years old
  • have a laceration of 4 cm on the face or 7 cm on the remainder of the body
  • Require procedural sedation to repair the laceration
Exclusion Criteria
  • Patients with abnormal nasal physiology which would not allow for adequate medication delivery
  • Unable to have a guardian present to consent on their behalf
  • Allergy to ketamine
  • Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
  • Presenting with a head injury associated with possible intracranial hypertension
  • Pregnancy
  • Lacerations that require repair from a consult service

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intranasal KetamineKetamine-
Intramuscular KetamineKetamine-
Primary Outcome Measures
NameTimeMethod
Onset of SedationEvery 60 seconds through study completion

Minutes it takes until the patient is cooperative enough for the procedure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath